Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.

Head and neck cancer Lymph node topography Lymph node yield Oral cavity Squamous cell carcinoma

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
02 2021
Historique:
received: 12 10 2020
revised: 19 11 2020
accepted: 23 11 2020
pubmed: 20 12 2020
medline: 16 11 2021
entrez: 19 12 2020
Statut: ppublish

Résumé

Nodal metastasis is an important prognostic factor in oral squamous cell carcinoma (OSCC). Detailed topographic study of metastasis can guide surgical and adjuvant radiation treatment protocols. Retrospective analysis of distribution of nodal spread was done by auditing pathology records of 1004 patients who underwent primary surgical management at our center. The median nodal yield was 41 (range of 9-166) nodes, per patient. Metastasis was present in 42.9% patients, of which 52.3% demonstrated extranodal extension. Reclassification by AJCC8 criteria resulted in up-staging in 35.6% patients (pN1, pN2a, pN2b, pN2c, pN3a and pN3b in 13.1%, 3.7%, 6.9%, 0.9%, 0%, 18.1% respectively). Ipsilateral levels Ib and IIa were involved in a quarter of patients each, while IIb, IV and V were involved in < 4%, 3% and 1% of patients, respectively. Contralateral nodal metastasis was present in 5.4%. Skip metastases to level IV were 2.2% and 1.2% for tongue and gingivobuccal primaries. Tongue primaries had a lower likelihood of involving level Ib, but higher of level IIa and III, compared to gingivobuccal primaries, and a lower likelihood of extranodal extension. Primary site did not influence nodal metastasis to levels IIb, IV or V, but other factors like lymphovascular invasion, pT stage and margin status had an influence. This large series with high nodal yield, shows low level of metastasis to level IIb, IV and V, which can help modify future guidelines for extent of surgery and avoid targeted adjuvant radiation to specific levels.

Identifiants

pubmed: 33341004
pii: S1368-8375(20)30551-0
doi: 10.1016/j.oraloncology.2020.105115
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105115

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Paromita Roy (P)

Oncopathology, Tata Medical Center, Kolkata, India. Electronic address: paromita.roy@tmckolkata.com.

Indranil Mallick (I)

Radiation Oncology, Tata Medical Center, Kolkata, India.

Indu Arun (I)

Oncopathology, Tata Medical Center, Kolkata, India.

Lateef Zameer (L)

Oncopathology, Tata Medical Center, Kolkata, India.

Debdeep Dey (D)

Oncopathology, Tata Medical Center, Kolkata, India.

Angad Singh (A)

Oncopathology, Tata Medical Center, Kolkata, India.

Sanjoy Chatterjee (S)

Radiation Oncology, Tata Medical Center, Kolkata, India.

Prateek Jain (P)

Head and Neck Surgery, Tata Medical Center, Kolkata, India.

Kapila Manikantan (K)

Head and Neck Surgery, Tata Medical Center, Kolkata, India.

Rajeev Sharan (R)

Head and Neck Surgery, Tata Medical Center, Kolkata, India.

Arun Pattatheyil (A)

Head and Neck Surgery, Tata Medical Center, Kolkata, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH